E Elevance Health, Inc.
| Market Cap | $66.37B |
| P/E Ratio | 11.93 |
| Forward P/E | 10.22 |
| Dividend Yield | 2.29% |
| Beta | 0.50 |
| 52W Range | $270.10 - $443.23 |
| # Hedge Funds | 11 |
| Sector | Healthcare |
| Industry | Healthcare Plans |
Hedge Fund Ownership
| Investor 11 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Glenn Greenberg Brave Warrior Advisors | 10.28% | $438.82M | 1,251,803 | Reduce 31.74% |
| Seth Klarman Baupost Group | 8.43% | $444.00K | 1,269,302 | Reduce 3.77% |
| Ruane Cunniff Ruane Cunniff & Goldfarb | 7.79% | $498.66M | 1,422,506 | Reduce 1.78% |
| Leon Cooperman Cooperman Leon G | 3.96% | $119.50M | 340,900 | — |
| First Eagle Investment Management First Eagle Investment Management | 2.48% | $1.41B | 4,022,874 | Add 0.61% |
| Bill Nygren Harris Associates LP | 2.12% | $1.68B | 4,794,445 | Add 50.31% |
| Yacktman Asset Management Yacktman Asset Management | 1.61% | $115.25M | 328,756 | Reduce 1.68% |
| Richard Pzena Pzena Investment Management | 0.23% | $75.83M | 216,322 | Reduce 0.18% |
| Tweedy Browne Co. Tweedy Browne Co LLC | 0.09% | $1.10M | 3,128 | Add 16.02% |
| FPA Queens Road Small Cap Value Fund Bragg Financial Advisors | 0.05% | $1.58M | 4,500 | — |
| Dodge & Cox Dodge & Cox | 0.00% | $455.00K | 1,300 | — |
Insider Trading
| Insider Name of the company insider who made the trade 4 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| SCHULMAN AMY W | Sale | 26 | $287.50 | $7.47K | 12 Mar 2026 | 12 Mar 2026 |
| Kendrick Charles Morgan JREVP & President, Commercial | Sale | 3,196 | $284.92 | $910.60K | 06 Mar 2026 | 06 Mar 2026 |
| COLLIS STEVEN H | Buy | 3,000 | $289.84 | $869.52K | 05 Mar 2026 | 06 Mar 2026 |
| Steven H CollisDirector | Buy | 3,000 | $289.84 | $869.52K | 05 Mar 2026 | 06 Mar 2026 |
Frequently Asked Questions
What is ELV stock price today?
Elevance Health, Inc. (ELV) is currently trading at $300.74. The stock has a 52-week range of $270.10 to $443.23 and a market capitalization of $66.37B.
Is ELV a good stock to buy in 2026?
Elevance Health, Inc. has a P/E ratio of 11.9 (forward P/E: 10.2), a dividend yield of 2.29%, and 1-year performance of -32.1%. 11 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ELV stock?
There have been 4 insider transactions for ELV in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ELV stock performed over the past year?
Elevance Health, Inc. (ELV) has returned -32.1% over the past 12 months. The stock traded between $270.10 and $443.23 during this period, and is currently at $300.74.
Which hedge funds own ELV (Elevance Health, Inc.)?
11 tracked hedge funds currently hold ELV in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ELV's market cap and valuation?
Elevance Health, Inc. (ELV) has a market capitalization of $66.37B. The trailing P/E ratio is 11.9 and forward P/E is 10.2. The stock is classified in the Healthcare sector.
What is ELV's revenue and profitability?
Elevance Health, Inc. reported revenue of $199.13B with net income of $5.66B and a profit margin of 0.03%. The stock has a beta of 0.50.
What sector is ELV in and who are its biggest institutional holders?
Elevance Health, Inc. (ELV) operates in the Healthcare sector. It is held by 11 tracked hedge funds. See the ownership table above for the complete list.